INKON Life Technology Co Ltd
INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of prevention / diagnosis / treatment / rehabilitation, providing medical services for tumors in China and internationally. It provides medical devices solution for radiotherapy, life support, image enhancement, and chronic disease treatment, as well as oncology medical services. The company was formerly known as… Read more
Market Cap & Net Worth: INKON Life Technology Co Ltd (300143)
INKON Life Technology Co Ltd (SHE:300143) has a market capitalization of $1.29 Billion (CN¥9.49 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #9263 globally and #1891 in its home market, demonstrating a 5.32% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INKON Life Technology Co Ltd's stock price CN¥12.66 by its total outstanding shares 749451604 (749.45 Million).
INKON Life Technology Co Ltd Market Cap History: 2015 to 2026
INKON Life Technology Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $1.59 Billion to $1.29 Billion (1.31% CAGR).
INKON Life Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INKON Life Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.60x
INKON Life Technology Co Ltd's market cap is 0.60 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
8.14x
INKON Life Technology Co Ltd's market cap is 8.14 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.59 Billion | $280.14 Million | $10.58 Million | 5.67x | 150.25x |
| 2016 | $1.37 Billion | $432.45 Million | $55.08 Million | 3.17x | 24.91x |
| 2017 | $1.38 Billion | $329.23 Million | $122.40 Million | 4.18x | 11.24x |
| 2018 | $928.48 Million | $504.02 Million | $50.17 Million | 1.84x | 18.51x |
| 2019 | $960.15 Million | $572.94 Million | -$703.41 Million | 1.68x | N/A |
| 2020 | $2.02 Billion | $661.05 Million | $128.11 Million | 3.06x | 15.79x |
| 2021 | $1.44 Billion | $1.09 Billion | -$364.08 Million | 1.32x | N/A |
| 2022 | $1.04 Billion | $1.16 Billion | -$595.92 Million | 0.90x | N/A |
| 2023 | $1.09 Billion | $1.47 Billion | $100.44 Million | 0.74x | 10.81x |
| 2024 | $939.72 Million | $1.56 Billion | $115.42 Million | 0.60x | 8.14x |
Competitor Companies of 300143 by Market Capitalization
Companies near INKON Life Technology Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to INKON Life Technology Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
INKON Life Technology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, INKON Life Technology Co Ltd's market cap moved from $1.59 Billion to $ 1.29 Billion, with a yearly change of 1.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.29 Billion | +28.14% |
| 2025 | CN¥1.01 Billion | +7.39% |
| 2024 | CN¥939.72 Million | -13.45% |
| 2023 | CN¥1.09 Billion | +4.52% |
| 2022 | CN¥1.04 Billion | -27.97% |
| 2021 | CN¥1.44 Billion | -28.69% |
| 2020 | CN¥2.02 Billion | +110.64% |
| 2019 | CN¥960.15 Million | +3.41% |
| 2018 | CN¥928.48 Million | -32.54% |
| 2017 | CN¥1.38 Billion | +0.31% |
| 2016 | CN¥1.37 Billion | -13.67% |
| 2015 | CN¥1.59 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of INKON Life Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.29 Billion USD |
| MoneyControl | $1.29 Billion USD |
| MarketWatch | $1.29 Billion USD |
| marketcap.company | $1.29 Billion USD |
| Reuters | $1.29 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.